Inspire Medical Systems (NYSE:INSP) Director Mudit K. Jain Sells 500 Shares

Share on StockTwits

Inspire Medical Systems (NYSE:INSP) Director Mudit K. Jain sold 500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $68.47, for a total transaction of $34,235.00. Following the transaction, the director now directly owns 6,097 shares of the company’s stock, valued at approximately $417,461.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Inspire Medical Systems stock traded up $0.05 during trading hours on Wednesday, hitting $72.27. 204,592 shares of the company traded hands, compared to its average volume of 298,025. The firm has a market cap of $1.79 billion, a P/E ratio of -48.18 and a beta of 1.27. The company has a quick ratio of 13.05, a current ratio of 13.42 and a debt-to-equity ratio of 0.17. The firm’s 50-day simple moving average is $62.36 and its two-hundred day simple moving average is $62.07. Inspire Medical Systems has a 1-year low of $35.43 and a 1-year high of $74.41.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Tuesday, November 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.43) by $0.09. The company had revenue of $20.86 million for the quarter, compared to analysts’ expectations of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. The business’s revenue was up 59.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.22) EPS. On average, equities research analysts predict that Inspire Medical Systems will post -1.46 earnings per share for the current year.

Several research analysts have recently weighed in on INSP shares. ValuEngine downgraded shares of Inspire Medical Systems from a “hold” rating to a “sell” rating in a research note on Thursday, October 31st. Dougherty & Co set a $78.00 price objective on shares of Inspire Medical Systems and gave the company a “buy” rating in a research note on Friday, September 27th. Berenberg Bank upgraded shares of Inspire Medical Systems from a “sell” rating to a “hold” rating and increased their price objective for the company from $46.00 to $51.00 in a research note on Wednesday, November 6th. Finally, Zacks Investment Research upgraded shares of Inspire Medical Systems from a “hold” rating to a “strong-buy” rating and set a $69.00 price target on the stock in a research report on Saturday, November 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. Inspire Medical Systems presently has an average rating of “Hold” and a consensus target price of $68.25.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Strs Ohio boosted its holdings in shares of Inspire Medical Systems by 8.7% during the second quarter. Strs Ohio now owns 2,500 shares of the company’s stock worth $151,000 after purchasing an additional 200 shares during the period. Advisory Services Network LLC raised its position in Inspire Medical Systems by 24.6% during the second quarter. Advisory Services Network LLC now owns 1,395 shares of the company’s stock valued at $85,000 after acquiring an additional 275 shares in the last quarter. California State Teachers Retirement System raised its position in Inspire Medical Systems by 1.8% during the third quarter. California State Teachers Retirement System now owns 20,887 shares of the company’s stock valued at $1,275,000 after acquiring an additional 377 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Inspire Medical Systems by 293.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 637 shares of the company’s stock valued at $39,000 after acquiring an additional 475 shares in the last quarter. Finally, Commonwealth Equity Services LLC raised its position in Inspire Medical Systems by 10.4% during the third quarter. Commonwealth Equity Services LLC now owns 7,023 shares of the company’s stock valued at $428,000 after acquiring an additional 660 shares in the last quarter. Institutional investors own 89.74% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Recommended Story: S&P/ASX 200 Index

Insider Buying and Selling by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.